FDA rejects Venatorx Pharmaceuticals’ new drug application for flagship product

Founded in 2010, Venatorx Pharmaceuticals is backed by more than $120 million in financing.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertise With Biotech Networks